Market Overview:
The global alopecia treatment market is expected to grow at a CAGR of 5.8% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing prevalence of alopecia, growing awareness about available treatments, and technological advancements in the field of hair restoration. The global alopecia treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into topical drugs, oral drugs, injectable drugs, hair transplant services and other treatments. Topical drugs are further sub-segmented into minoxidil solutions and foam formulations; oral medications are sub-segmented into finasteride tablets and dutasteride capsules; injectables are sub-segmented into platelet rich plasma (PRP) injections and corticosteroid injections; hair transplant services are further divided into follicular unit extraction (FUE) procedures and follicular unit strip surgery (FUSS); while other treatments include laser therapy devices and scalp cooling systems/devices. On the basis of application, hospitals accounted for majority share in 2017 owing to availability of advanced technologies for treating various types of alopecias such as tractional alopecia or lichen planus induced baldness etc.
Product Definition:
Alopecia is a medical condition which results in the loss of hair. There are many different types of alopecia, with different causes and treatments. Alopecia treatment refers to any method used to treat or prevent alopecia.
Topical Drugs:
Topical drugs are those used to treat diseases and conditions that are not related to the scalp. They may be prescribed for skin disorders such as psoriasis, eczema, acne rosacea or any other disease/condition that is not responsive to OTC medications. Topical drugs can be administered directly into the affected area by a healthcare professional or self-administered with proper training.
Oral Drugs:
Oral drugs are medicines that are taken by mouth. They may be formulated in different ways, such as tablets, capsules, lozenges or gels and syrups. The most commonly used medications for alopecia include corticosteroids (e.g., prednisolone), antibiotics (e.g., doxycycline), immunosuppressants (e.g.
Application Insights:
The others segment held the largest share of the market in 2017. Other applications include hairpiece manufacturing and research. The demand for alopecia treatments is increasing among individuals aged 40 years and above as compared to younger patients due to increased awareness about hair loss problems coupled with rising disposable income levels in developed economies such as North America and Europe. This trend is expected to continue over the forecast period, thereby driving segment growth during the study period.
Hair transplantation procedures are performed by dermatologists, plastic surgeons, and other physicians trained specifically in this procedure known as a Hair Transplantation Specialty (HTS). These professionals have highly sophisticated equipment used for harvesting hairs from areas like arms or legs that can be used for creating a full head of natural looking hair after treatment with FUE technique or strip method which has been proven more effective than FUT technique currently available in clinics worldwide since 2012-2016.
Regional Analysis:
North America dominated the global market in 2017 owing to a rise in awareness about alopecia treatments, availability of highly advanced technologies and high disposable income of patients. Moreover, increasing prevalence of autoimmune diseases and growing number of cosmetic surgeries are also driving the regional market. According to an article published by International Society Of Hair Restoration Surgery (ISHRS), around 50 million Americans have had a hair transplant surgery which is more than double compared to 2001.
Asia Pacific region is expected to grow at the highest rate during the forecast period due to factors such as improving healthcare infrastructure, rising patient awareness levels about available treatment options & efficacy, increase in medical tourism for hair restoration procedures & other dermatology treatments and booming economy especially after China’s reform & opening up policies that attracted many international companies including Kose Corp.
Growth Factors:
- Increasing prevalence of alopecia
- Growing awareness about available treatment options for alopecia
- Rising demand for hair restoration procedures
- Technological advancements in the field of alopecia treatment
- Availability of government funding and private investment for research and development
Scope Of The Report
Report Attributes
Report Details
Report Title
Alopecia Treatment Market Research Report
By Type
Topical Drugs, Oral Drugs, Injectable, Hair Transplant Services, Other
By Application
Hospitals, Dermatology And Trichology Clinics, Home Care Settings, Other
By Companies
Teva Pharmaceutical Industries, Merck, Johnson＆Johnson, Reddy's Laboratories, Cipla, Cellmid, Himalaya Drug, Taisho Pharmaceutical Holdings
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
186
Number of Tables & Figures
131
Customization Available
Yes, the report can be customized as per your need.
Global Alopecia Treatment Market Report Segments:
The global Alopecia Treatment market is segmented on the basis of:
Types
Topical Drugs, Oral Drugs, Injectable, Hair Transplant Services, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Dermatology And Trichology Clinics, Home Care Settings, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Teva Pharmaceutical Industries
- Merck
- Johnson＆Johnson
- Reddy's Laboratories
- Cipla
- Cellmid
- Himalaya Drug
- Taisho Pharmaceutical Holdings
Highlights of The Alopecia Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Topical Drugs
- Oral Drugs
- Injectable
- Hair Transplant Services
- Other
- By Application:
- Hospitals
- Dermatology And Trichology Clinics
- Home Care Settings
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Alopecia Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Alopecia is a medical condition in which the hair falls out. There are many types of alopecia, including baldness, thinning hair, and total baldness. Alopecia can be treated with various treatments such as medication, surgery, or radiation therapy.
Some of the major companies in the alopecia treatment market are Teva Pharmaceutical Industries, Merck, Johnson＆Johnson, Reddy's Laboratories, Cipla, Cellmid, Himalaya Drug, Taisho Pharmaceutical Holdings.
The alopecia treatment market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Alopecia Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Alopecia Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Alopecia Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Alopecia Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Alopecia Treatment Market Size & Forecast, 2020-2028
4.5.1 Alopecia Treatment Market Size and Y-o-Y Growth
4.5.2 Alopecia Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Topical Drugs
5.2.2 Oral Drugs
5.2.3 Injectable
5.2.4 Hair Transplant Services
5.2.5 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Dermatology And Trichology Clinics
6.2.3 Home Care Settings
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Alopecia Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Alopecia Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Topical Drugs
9.6.2 Oral Drugs
9.6.3 Injectable
9.6.4 Hair Transplant Services
9.6.5 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Dermatology And Trichology Clinics
9.10.3 Home Care Settings
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Topical Drugs
10.6.2 Oral Drugs
10.6.3 Injectable
10.6.4 Hair Transplant Services
10.6.5 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Dermatology And Trichology Clinics
10.10.3 Home Care Settings
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Topical Drugs
11.6.2 Oral Drugs
11.6.3 Injectable
11.6.4 Hair Transplant Services
11.6.5 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Dermatology And Trichology Clinics
11.10.3 Home Care Settings
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Topical Drugs
12.6.2 Oral Drugs
12.6.3 Injectable
12.6.4 Hair Transplant Services
12.6.5 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Dermatology And Trichology Clinics
12.10.3 Home Care Settings
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Topical Drugs
13.6.2 Oral Drugs
13.6.3 Injectable
13.6.4 Hair Transplant Services
13.6.5 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Dermatology And Trichology Clinics
13.10.3 Home Care Settings
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Alopecia Treatment Market: Competitive Dashboard
14.2 Global Alopecia Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Teva Pharmaceutical Industries
14.3.2 Merck
14.3.3 Johnson＆Johnson
14.3.4 Reddy's Laboratories
14.3.5 Cipla
14.3.6 Cellmid
14.3.7 Himalaya Drug
14.3.8 Taisho Pharmaceutical Holdings
